Boost Run: 2026 Ramp Makes This SPAC Worth Buying Seeking Alpha
Brandon Hall Group™ Launches Study On the State of Skills Strategy in 2026
New research examines who owns skills strategy, how HR and L&D collaborate on it and why siloed skills data is leaving the workforce underprepared for what comes next.
New research examines who owns skills strategy, how HR and L&D collaborate on it and why siloed skills data is leaving the workforce underprepared for what comes next.
Four days until GraniteShares SKUU and SKDD go live
New York, July 09, 2026 (GLOBE NEWSWIRE) — GraniteShares
Four Things to Know About the Deadly Counterfeit Air-Bag Parts in U.S. Cars
Since 2023, at least 10 deaths in the U.S. have been linked to air-bag parts with markings of a Chinese manufacturer known as DTN Airbag.
International Poverty Forum to Convene Its 2027 Annual Assembly and Think Tank in Saint Lucia
On the 10th anniversary of its founding, in partnership with the government and people of Saint Lucia, IPF brings its global, action-driven approach to poverty eradication to the Caribbean for the first time, March 19–21, 2027
On the 10th anniversary of its founding, in partnership with the government and people of Saint Lucia, IPF brings its global, action-driven approach to poverty eradication to the Caribbean for the first time, March 19–21, 2027
Money Management International Launches Financial Wellbeing AI Lab, Names Inaugural Advisory Council, and Kicks Off Summer Fellowship with NextLadder Ventures, The MIT Bike Shop and Anthropic
New applied AI lab will work to close the gap between Americans who seek financial counseling and those who successfully connect with help; inaugural projects include a summer fellowship with graduate researchers from MIT and Harvard
New applied AI lab will work to close the gap between Americans who seek financial counseling and those who successfully connect with help; inaugural projects include a summer fellowship with graduate researchers from MIT and Harvard
Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
HUNTSVILLE, Ala., July 09, 2026 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today announced the completion of sentinel dosing in Cohort 1 of its ongoing Phase 1b registrational clinical trial evaluating SER-252 in patients with advanced Parkinson’s disease.
Federal Regulator Warns Robotaxis Are a ‘Danger’ to the Public
The National Highway Traffic Safety Administration told autonomous-vehicle developers that their cars must interact better with first responders.
Registration Opens for NAB Show New York 2026, the East Coast Marketplace for Media Innovation
Two days of programming will explore AI, creators, streaming, sports and broadcasting alongside the technologies and business strategies shaping the future of media
Two days of programming will explore AI, creators, streaming, sports and broadcasting alongside the technologies and business strategies shaping the future of media
TRUGOLF LINKS CHICAGOLAND REGIONAL DEVELOPER SIGNS LEASE FOR ROMEO TOWN CENTER
Flagship Location Coming to Romeoville Featuring “Eatertainment” Experience
Lawmatics Unveils Merlin, a Suite of AI Features Designed to Help Law Firms Grow
The suite’s three AI features work together to qualify incoming leads, engage prospects around the clock, and turn firm data into plain-language answers.
The suite's three AI features work together to qualify incoming leads, engage prospects around the clock, and turn firm data into plain-language answers.
TekniPlex Recognizes FY2026 TeknoVation Award Winners
Advancing Healthcare Through Materials Science and Manufacturing Innovation
Advancing Healthcare Through Materials Science and Manufacturing Innovation
Anti-Obesity Drugs Market Size to Reach USD 70.31 Billion by 2035 | SNS Insider
The U.S. Anti-Obesity Drugs Market is projected to grow from USD 2.27 Billion in 2025 to USD 19.64 Billion by 2035, while Europe is expected to expand from USD 1.88 Billion to USD 16.94 Billion, supported by increasing GLP-1 therapy adoption, broader reimbursement coverage, and obesity treatment innovation.
The U.S. Anti-Obesity Drugs Market is projected to grow from USD 2.27 Billion in 2025 to USD 19.64 Billion by 2035, while Europe is expected to expand from USD 1.88 Billion to USD 16.94 Billion, supported by increasing GLP-1 therapy adoption, broader reimbursement coverage, and obesity treatment innovation.
CALL FOR ENTRIES – XYPN LIVE 2026 AdviceTech Competition
AdviceTech competition nominations open through July 16, 2026
AdviceTech competition nominations open through July 16, 2026
New Study Links Career Literacy to Broader Job Searches, Greater Economic Security
Large, multi-year study demonstrates early career literacy improves outcomes, while highlighting the need for free resources to close opportunity gaps
Large, multi-year study demonstrates early career literacy improves outcomes, while highlighting the need for free resources to close opportunity gaps
Flush Smart: 7 Tips for Good Bathroom Etiquette
Regardless of who you’re sharing a household with, good bathroom etiquette can help save your sanity – and your pipes.
‘Expectations on Every Calorie’—PepsiCo’s CEO Is Navigating GLP-1s and Inflation
Ramon Laguarta sees opportunities in smaller-portion products and teas for mental focus.